---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-006916"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2022-02-11T23:59:59+00:00"
generated_at: "2026-06-27T08:55:55.062859+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ImmuCell: Dr. Joseph Crabb resigns as officer/employee; remains as consultant for Re-Tain FDA approvals

## Summary
- Dr. Joseph H. Crabb resigned from all employee and officer roles effective Feb 11, 2022.
- Crabb engaged as consultant/advisor to President; term through April 30, 2023 or FDA approval date.
- Compensation: $70,000 payment due upon receipt of all FDA approvals for Re-Tain (Nisin) if still consulting.
- Payment also triggered by change of control or sale/license of Nisin rights while consulting.

## SEC filing metadata
- accession: 0001213900-22-006916
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2022-02-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000121390022006916/0001213900-22-006916-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000121390022006916/ea155463-8k_immucell.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-006916
- JSON: https://secwatch.observer/filing/0001213900-22-006916.json
- Plain text: https://secwatch.observer/filing/0001213900-22-006916.txt

## Key facts
- Executive change
  Dr. Joseph H. Crabb resigned as other_named_officer at IMMUCELL CORP /DE/.
  - Action: resigned
  source text: On February 11, 2022, Dr. Joseph H. Crabb resigned from all positions he held at the Company, including without limitation as an employee and an officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390022006916/0001213900-22-006916-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.